Share
367 Posts.
lightbulb Created with Sketch. 32
clock Created with Sketch. 01/09/24
22:43
Share
Originally posted by Shellbell:
↑
It seems that there are a number of things at play here. Its obvious that big bucks had to be spent on a pipeline of technologies for CHM to build the business model it now has... and start bringing some of the tech to Aust to foster our own IP and take advantage of the financial benefits available here for clinical R&D. CHM 2101 is the exception - the multi-trial sites are all in the US (at this stage). The timing of the potential CR ann, IMO, coincided with the CDH17 CAR-T trial start (which was delayed til mid-year) and coincided with the recent cost-cutting measures. EVERYONE (including the grumbling retail) to take advantage of the subsequent price suppression? Who is likely to be Mr Market to drive the SP (up or down) ahead of such news? The sophies in the know, the Bell Potters of this world (making a killing in the run up to disclosure or otherwise) of such information before a typical pullback. A lot can happen, share-wise, in a month.
Expand
You're exactly right shellbell, information/knowledge= $power$ and government officials leak information that has massive effects, whether it's the amount of nuclear power plant proposals, or changes in legislation etc etc
(20min delay)